GlassScriptPhysician profile
Barron Douglas Elleby
NPI 1861536021
$1,338.81
in general payments reported to CMS, 2019-2025
12 companies · $680 in 2025
The $680 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2021: $54.59 · 2022: $122 · 2023: $95.68 · 2024: $257 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $465.38 | 2023-2025 | Apligraf, Puraply Wound Matrix, Puraply |
| Mimedx Group, INC. | $287.21 | 2024-2025 | |
| Orthofix Medical, INC. | $181.27 | 2023-2025 | Physio-Stim, Accelstim |
| Abbott Laboratories | $122.17 | 2022 | |
| Bioventus LLC | $69.80 | 2021-2023 | Durolane |
| Abbvie INC. | $50.39 | 2024-2025 | |
| Smith+Nephew, INC. | $46.43 | 2019 | |
| Merck Sharp & Dohme LLC | $38.21 | 2019 | |
| Allergan, INC. | $31.08 | 2019 | |
| Integra Lifesciences Corporation | $17.61 | 2024 | Tcc-Ez |
| Horizon Therapeutics Plc | $14.64 | 2023 | Krystexxa |
| Melinta Therapeutics, LLC | $14.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barron Elleby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.